Technology News and Research

RSS

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

OB Complete Gold is a breakthrough innovation in prenatal vitamin supplements that contains the advanced technology OmEGGa DHA, providing a novel egg-based DHA that comes from cage-free hens.

25 Feb 2016

Gene expression analysis points metastatic CRC patient to successful irbesartan therapy

A patient with recurrent metastatic colorectal cancer has been successfully treated with the angiotensin receptor blocker irbesartan, researchers report.

24 Feb 2016

Doctors use supercomputers to create 3D models from heart disease patients

University of Melbourne doctors and engineers are using supercomputers to create 3D models from patients with heart disease, with photos from a camera thinner than a human hair.

24 Feb 2016

Does simulated based training bring better value healthcare? An interview with Prof Sir Muir Gray, Former Chief Knowledge Officer of the NHS

We have to think of the world that we are leaving, the world we are moving into. The last fifty years in healthcare, have seen the advent of hip replacement, cardiac bypass, systematic reviews. But at the end of fifty years, every country is facing five problems.

24 Feb 2016

PolyPid closes $22 million private equity financing

PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.

24 Feb 2016

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

24 Feb 2016

Gamma Knife and RapidArc equally effective at eradicating cancer in the brain

While two advanced radiosurgery approaches — Gamma Knife and RapidArc — offer different strengths, they are equally effective at eradicating cancer in the brain, say researchers at Sidney Kimmel Cancer Center.

24 Feb 2016

New clinical trial launched to test potential drug that could help immune system combat cancer

Cancer Research UK's Centre for Drug Development, in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours.

24 Feb 2016

MR Solutions introduces new 3D in vivo confocal microscope for preclinical research

MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs.

From MR Solutions 24 Feb 2016

New smart seat cushion may relieve painful pressure ulcers for wheelchair users

Modern-day wheelchairs provide a full range of mobility solutions to those who cannot walk, but many users still battle an unwanted side effect: painful ulcers caused by sitting for long periods in the same position.

24 Feb 2016

Ohio State researchers working on new way to treat drug-resistant cancer

Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of--only it's not a Trojan horse, but DNA that hides the invading force.

24 Feb 2016

UOC initiates U-Motion II+ Acetabular System and UTF Reduced Stem study in patients receiving primary THA

United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced the start of patient enrollment in a follow-up study in the U.S. of the commercially available U-Motion II+ Acetabular System and UTF Reduced Stem in patients receiving primary total hip arthroplasty.

24 Feb 2016

Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou’s intellectual property.

24 Feb 2016

ONR researcher explores how explosive shock waves contribute to traumatic brain injury

Today's warfighters are outfitted with body armor strong enough to withstand shrapnel from a bomb or other explosive device. One debilitating threat from a blast, however, is a force they can't see--the explosive shock wave itself.

24 Feb 2016

Inadequate dietary intake of essential amino acids and nutrient choline linked to stunting

Worldwide, an estimated 25 percent of children under age 5 suffer from stunted growth and development. The most visible characteristic is short stature, but the effects of stunting are far more profound: The condition prevents children from reaching their cognitive potential; makes them more susceptible to illness and infection; and shortens their life spans.

24 Feb 2016

New computer program and electronic stethoscope developed to diagnose lung problems

The classic stethoscope has entered the digital age. Medical researchers have created a computer program that connects to an electronic stethoscope to classify lung sounds into five common diagnostic categories.

24 Feb 2016

Maryland Proton Treatment Center completes first patient treatment with Varian ProBeam system

Varian Medical Systems, today announced the Maryland Proton Treatment Center successfully completed its first patient treatment with the Varian ProBeam system. The MPTC at the University of Maryland BioPark in West Baltimore houses five treatment rooms and is the first in the Eastern US to offer image-guided intensity-modulated proton therapy (IMPT) with a ProBeam system.

24 Feb 2016

UCLA researchers pioneer more effective approach to improve cancer treatment

Despite a growing interest in developing non-invasive methods to identify rare cancer cells or cancer cell DNA in blood, current techniques remain complicated and often prohibitively expensive. Now, UCLA researchers have pioneered a more effective approach to these "liquid biopsies" that has the potential to offer a streamlined and low-cost solution for people with the disease.

23 Feb 2016

Dapivirine ring can help prevent HIV-1 infection in women

In an important scientific achievement for women's health, two large Phase III clinical trials -- The Ring Study and ASPIRE -- have shown that a monthly vaginal ring containing the antiretroviral drug (ARV) dapivirine can safely help prevent HIV-1 infection in women.

23 Feb 2016

Researchers devise new approach to improve current T-cell therapy methods

T-cell therapy, a form of immunotherapy that uses a patient's own immune cells to attack their cancer, has been making waves recently. The "living" therapy involves engineering the patient's T cells in the laboratory to carry new proteins that guide the immune cells directly to tumor cells, allowing the engineered T cells to attack and kill the cancer.

23 Feb 2016

Technology News and Research

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

Gene expression analysis points metastatic CRC patient to successful irbesartan therapy

Doctors use supercomputers to create 3D models from heart disease patients

Does simulated based training bring better value healthcare? An interview with Prof Sir Muir Gray, Former Chief Knowledge Officer of the NHS

PolyPid closes $22 million private equity financing

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Gamma Knife and RapidArc equally effective at eradicating cancer in the brain

New clinical trial launched to test potential drug that could help immune system combat cancer

MR Solutions introduces new 3D in vivo confocal microscope for preclinical research

New smart seat cushion may relieve painful pressure ulcers for wheelchair users

Ohio State researchers working on new way to treat drug-resistant cancer

UOC initiates U-Motion II+ Acetabular System and UTF Reduced Stem study in patients receiving primary THA

Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

ONR researcher explores how explosive shock waves contribute to traumatic brain injury

Inadequate dietary intake of essential amino acids and nutrient choline linked to stunting

New computer program and electronic stethoscope developed to diagnose lung problems

Maryland Proton Treatment Center completes first patient treatment with Varian ProBeam system

UCLA researchers pioneer more effective approach to improve cancer treatment

Dapivirine ring can help prevent HIV-1 infection in women

Researchers devise new approach to improve current T-cell therapy methods

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News